• No results found

Cover Page The handle

N/A
N/A
Protected

Academic year: 2021

Share "Cover Page The handle"

Copied!
9
0
0

Bezig met laden.... (Bekijk nu de volledige tekst)

Hele tekst

(1)Cover Page. The handle http://hdl.handle.net/1887/72625 holds various files of this Leiden University dissertation. Author: Hensen, L.C.R. Title: Cardiac mechanics in chronic kidney disease Issue Date: 2019-05-15.

(2) Chapter 1 GENER AL INTRODUC TION AND OUTLINE OF THE THESIS.

(3) Chapter 1. GENERAL INTRODUCTION AND OUTLINE OF THE THESIS Introduction. Àœ˜ˆVŽˆ`˜iÞ`ˆÃi>Ãi­ 

(4) ®ˆÃ>ܜÀ`܈`i}ÀœÜˆ˜}i«ˆ`i“ˆV>ÃÜVˆ>Ìi`ÜˆÌ  an increased risk of cardiovascular morbidity and mortality.1-4 Heart failure is particularly frequent among patients with CKD.2 Pressure and volume overload >˜`˜œ˜‡ i“œ`ޘ>“ˆVv>V̜ÀÃ>ÃÜVˆ>Ìi`ÜˆÌ  

(5) ˆ˜`ÕViivÌÛi˜ÌÀˆVՏ>À­6® Þ«iÀÌÀœ« Þ]Ài`ÕViV>«ˆ>ÀÞ`i˜ÃˆÌÞ>˜`ˆ˜VÀi>Ãi“ÞœV>À`ˆ>wLÀœÃˆÃÌ >̏i>` ̜6`ˆ>Ã̜ˆV>˜`ÃÞÃ̜ˆV`ÞÃv՘V̈œ˜°5 These processes have been proposed as important determinants of increased mortality in this population.5 The most frequent cause of death in patients with advanced CKD is sudden cardiac death; there is an enhanced arrhythmogenicity due to an increased «ÀiÛ>i˜ViœvV>À`ˆ>VÀˆÃŽv>V̜ÀÃÃÕV >ÃVœÀœ˜>ÀÞ>ÀÌiÀÞ`ˆÃi>Ãi]6 Þ«iÀÌÀœ« Þ >˜`“ÞœV>À`ˆ>wLÀœÃˆÃ]>ÃÜi>Øœ˜‡V>À`ˆ>V­ 

(6) ‡Ã«iVˆwV®ÀˆÃŽv>V̜ÀÃÃÕV  as electrolyte alterations, sympathetic hyperactivity, uremia and anemia. 2,6 Patients with CKD also have an increased risk for developing valvular heart disease due to hemodynamic factors and metabolic pathways that promote Û>ÛՏ>À V>VˆwV>̈œ˜] V>À`ˆ>V `ˆ>Ì>̈œ˜ >˜` ˆ˜viV̈Ûi i˜`œV>À`ˆÌˆÃ°7,8 Finally, >ÌÀˆ>wLÀˆ>̈œ˜ˆÃ«>À̈VՏ>ÀÞvÀiµÕi˜Ìˆ˜«>̈i˜ÌÃÜˆÌ >`Û>˜Vi` 

(7) `Õi̜ electrical and structural remodeling of the atrial myocardium as a consequence of hemodynamic and metabolic disturbances.9-13 Left ventricular systolic dysfunction in patients with chronic kidney disease 6iiV̈œ˜vÀ>V̈œ˜­6 ®]V>VՏ>Ìi`vÀœ“Ìܜ‡`ˆ“i˜Ãˆœ˜>iV œV>À`ˆœ}À>« Þ] ˆÃÌ i“œÃÌvÀiµÕi˜ÌÞÕÃi`«>À>“iÌiÀ̜`iw˜i6ÃÞÃ̜ˆV­`ÞÇ®v՘V̈œ˜14, and is strongly associated with HF and increased mortality in patients with CKD.15,16 œÜiÛiÀ]6  >ÃLii˜à œÜ˜À>Ì iÀˆ˜Ãi˜ÃˆÌˆÛi̜Ì i`iÌiV̈œ˜œv6ÃÞÃ̜ˆV `ÞÃv՘V̈œ˜]«>À̈VՏ>ÀÞˆ˜«>̈i˜ÌÃÜˆÌ  

(8) °˜Ì iÃi«>̈i˜ÌÃ]6 Þ«iÀÌÀœ« Þ >˜` V >˜}ià ˆ˜ Ì i 6 ÃÌÀÕVÌÕÀi “>Þ i>` ̜ ÃÕL̏i 6 ÃÞÃ̜ˆV `ÞÃv՘V̈œ˜ `iëˆÌi«ÀiÃiÀÛi`6 °17 In the last years, several advances in echocardiography ÀiÃՏÌi`ˆ˜˜œÛiˆ˜`ˆViȘœÀ`iÀ̜ˆ“«ÀœÛiV >À>VÌiÀˆâ>̈œ˜œv6v՘V̈œ˜°/ܜ‡ dimensional speckle tracking echocardiography provides more insight in cardiac “iV >˜ˆVÃ>˜`6«iÀvœÀ“>˜Vi°6}œL>œ˜}ˆÌÕ`ˆ˜>ÃÌÀ>ˆ˜­-®]>ÃÃiÃÃi`ÜˆÌ  two-dimensional speckle tracking echocardiography, may provide more detailed ˆ˜vœÀ“>̈œ˜œ˜6ÃÞÃ̜ˆVv՘V̈œ˜°18 9iÌ]`>Ì>œ˜Ì i«ÀiÛ>i˜ViœvÃÕL̏i6 ÃÞÃ̜ˆV`ÞÃv՘V̈œ˜]>VVœÀ`ˆ˜}̜6-ˆ˜«>̈i˜ÌÃÜˆÌ  

(9) >˜`«ÀiÃiÀÛi`. 10.

(10) General Introduction. 6  >Ûi˜œÌLii˜iÝ«œÀi`̜`>Ìi°/ iˆ˜VÀi“i˜Ì>«Àœ}˜œÃ̈VÛ>Õiœv6 -œÛiÀ6  >ÃLii˜`i“œ˜ÃÌÀ>Ìi`ˆ˜«>̈i˜ÌÃÜˆÌ Û>ÀˆœÕÃV>À`ˆœÛ>ÃVՏ>À `ˆÃi>Ãià ­ˆÃV i“ˆV i>ÀÌ `ˆÃi>Ãi] Û>ÛՏ>À i>ÀÌ `ˆÃi>Ãi >˜` i>ÀÌ v>ˆÕÀi®°19 œÜiÛiÀ]ˆÌ̏iˆÃŽ˜œÜ˜>LœÕÌÌ i>ÃÜVˆ>̈œ˜LiÌÜii˜6->˜`ÃÕÀۈÛ>ˆ˜ patients with CKD.19 6 “iV >˜ˆV> `ˆÃ«iÀȜ˜ Ài«ÀiÃi˜Ìà 6 “iV >˜ˆV> `ÞÃÃޘV Àœ˜Þ >˜` ˆÃ “i>ÃÕÀi`ÜˆÌ Ìܜ‡`ˆ“i˜Ãˆœ˜>ëiVŽiÌÀ>VŽˆ˜}iV œV>À`ˆœ}À>« Þ°6->˜` 6“iV >˜ˆV>`ˆÃ«iÀȜ˜>Ài«œÌi˜Ìˆ>ÀˆÃŽ“>ÀŽiÀÃœvÛi˜ÌÀˆVՏ>À>ÀÀ ÞÌ “ˆ>Ș «>̈i˜ÌÃÜˆÌ  

(11) °*>̈i˜ÌÃÜˆÌ >`Û>˜Vi` 

(12) “>ÞLi˜iwÌvÀœ“>˜ˆ“«>˜Ì>Li V>À`ˆœÛiÀÌiÀ`iwLÀˆ>̜À­

(13) ®vœÀ«ÀiÛi˜Ìˆœ˜œvÃÕ``i˜V>À`ˆ>V`i>Ì °œÜiÛiÀ] they also show an increased risk of ICD-related complications.20-22 Therefore, Ì iÀi ˆÃ >˜ ՘“iÌ ˜ii` vœÀ >VVÕÀ>Ìi ÀˆÃŽ ÃÌÀ>̈wV>̈œ˜ ̜œÃ ̜ ˆ`i˜ÌˆvÞ 

(14)  patients at risk of ventricular arrhythmias and sudden cardiac death. Valvular heart disease in patients with chronic kidney disease Patients with CKD have an increased risk for developing valvular heart disease, however they are often denied or not referred to surgery due to the increased operative risk.23,24/ i«Àœ}˜œÃ̈Vˆ“«ˆV>̈œ˜Ãœv՘ÌÀi>Ìi`ÃiÛiÀi6

(15) ˆ˜Ì i }i˜iÀ>«œ«Õ>̈œ˜>ÀiÜiŽ˜œÜ˜]LÕÌ >Ûi˜œÌLii˜ÃÌÕ`ˆi`iÝÌi˜ÃˆÛiÞˆ˜ patients with CKD.25 Underscoring the need of additional studies regarding the prevalence of valvular heart disease in patients with CKD and the frequency of referral for surgical or transcatheter valve intervention. In CKD patients, valvular calcium is an important underlying mechanism œvÛ>Ûi`ÞÃv՘V̈œ˜°6>ÛՏ>ÀV>VˆÕ“ˆÃ>ÃÜVˆ>Ìi`ÜˆÌ >˜ˆ˜VÀi>Ãi`ÀˆÃŽœv all-cause mortality in patients with end-stage renal disease.26,27 However, the prognostic implications of left-sided valve calcium in patients with stage 2 and Î 

(16) ­i,œvÈä‡n™“ɓˆ˜É£°ÇΓÔ>˜`Îä‡x™“ɓˆ˜É£°ÇΓÔÀiëiV̈ÛiÞ® are unknown. #VTKCNƂDTKNNCVKQPKPRCVKGPVUYKVJEJTQPKEMKFPG[FKUGCUG ƂÌÀˆ>wLÀˆ>̈œ˜ˆÃÛiÀÞVœ““œ˜ˆ˜i˜`‡ÃÌ>}iÀi˜>`ˆÃi>Ãi«>̈i˜ÌÃ>˜`Ì i ˆ˜Vˆ`i˜Viœv˜i܏Þ`ˆ>}˜œÃi`>ÌÀˆ>wLÀˆ>̈œ˜ˆ˜œ`iÀ«>̈i˜ÌȘˆÌˆ>̈˜}`ˆ>ÞÈà is 5-fold higher than in the general population.9-11 Electrical and structural Ài“œ`iˆ˜}œvÌ i>ÌÀˆ>“ÞœV>À`ˆÕ“ÃiÀÛiÃ>Ã>ÃÕLÃÌÀ>ÌivœÀ>ÌÀˆ>wLÀˆ>̈œ˜°12 In patients with end-stage renal disease, the metabolic and hemodynamic `ˆÃÌÕÀL>˜ViÃ>ÃÜVˆ>Ìi`ÜˆÌ `ˆ>ÞÈÓ>Þ“œ`Տ>ÌiÌ i>ÌÀˆ>wLÀˆ>̈œ˜ÃÕLÃÌÀ>Ìi. 11.

(17) Chapter 1. Vœ˜ÌÀˆLṎ˜}̜Ì i ˆ} ˆ˜Vˆ`i˜Viœv>ÌÀˆ>wLÀˆ>̈œ˜°13 To date, the structural Ài“œ`iˆ˜}œvÌ iivÌ>ÌÀˆÕ“ >ØœÌLii˜V >À>VÌiÀˆâi`ˆ˜Ì ˆÃ}ÀœÕ«œv«>̈i˜Ìð Outline of the thesis The aim of this thesis was to evaluate cardiac mechanics using two-dimensional ­Ã«iVŽi ÌÀ>VŽˆ˜}® iV œV>À`ˆœ}À>« Þ >˜` VœÀœ˜>ÀÞ Vœ“«ÕÌi` ̜“œ}À>« Þ >˜}ˆœ}À>« Þ ˆ˜ «>̈i˜ÌÃ ÜˆÌ  

(18)  ̜ `iw˜i Ì i «ÀiÛ>i˜Vi >˜` «Àœ}˜œÃ̈V implications of cardiovascular diseases. In Part 1 the value of two-dimensional speckle tracking echocardiography was ˆ˜ÛiÃ̈}>Ìi`vœÀ>ÃÃiÃȘ}6->˜`6“iV >˜ˆV>`ˆÃ«iÀȜ˜ˆ˜«>̈i˜ÌÃÜˆÌ  CKD and its prognostic implications. Chapter 2 >˜>ÞÃiÃ6-]>ÃÃiÃÃi`LÞ two-dimensional speckle tracking echocardiography, in pre-dialysis and dialysis «>̈i˜ÌÃÜˆÌ «ÀiÃiÀÛi`6 °Chapter 3 evaluates the prognostic implications œv6-ˆ˜«Ài‡`ˆ>ÞÈÃ>˜``ˆ>ÞÈë>̈i˜ÌðChapter 4 discusses the value of 6“iV >˜ˆV>`ˆÃ«iÀȜ˜>˜`6->ÃÀˆÃŽ“>ÀŽiÀÃœvÛi˜ÌÀˆVՏ>À>ÀÀ ÞÌ “ˆ>à in pre-dialysis and dialysis patients. Part II focuses on the prevalence and prognostic implications of valvular heart disease and mitral and aortic valve calcium in patients with CKD. Chapter 5 investigates the prevalence and prognostic value of valvular heart disease in pre-dialysis and dialysis patients. Chapter 6 describes the prevalence and prognostic implications of mitral and aortic valve calcium in patients with CKD. Part III vœVÕÃiÃœ˜>ÌÀˆ>wLÀˆ>̈œ˜ˆ˜«>̈i˜ÌÃÜˆÌ i˜`‡ÃÌ>}iÀi˜>`ˆÃi>Ãi° Chapter 7 provides more insight on the echocardiographic associates of atrial wLÀˆ>̈œ˜ˆ˜«>̈i˜ÌÃÜˆÌ i˜`‡ÃÌ>}iÀi˜>`ˆÃi>Ãi°. 12.

(19) General Introduction. REFERENCES £° œƂ-] iÀ̜Ü]>˜

(20) ]V ՏœV  CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular iÛi˜ÌÃ]>˜` œÃ«ˆÌ>ˆâ>̈œ˜°N Engl J Med 2004;351:1296-1305. 2. United States Renal Data System. 2016 USRDS annual data repor t: Epidemiology of kidney disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 2016. ΰ 7i˜ *] i˜}/9]/Ã>ˆ] >˜}9 ] Chan HT, Tsai SP, Chiang PH, Hsu CC, -՘}*]ÃÕ9]7i˜-°Ƃ‡V>ÕÃi mortality attributable to chronic kidney disease: a prospective cohort study based on 462 293 adults in Taiwan. Lancet 2008;371:2173-2182. {° >`L>˜ -] Àˆ}>˜Ìˆ ] iÀÀ *]

(21) ՘ÃÌ>˜

(22) 7]7iLœÀ˜/Ƃ]<ˆ““iÌ*<] Atkins RC. Prevalence of kidney damage in Australian adults: The AusDiab kidney study. J Am Soc Nephrol 2003;14:S131138. x° iÀâœ} Ƃ]ƂȘ}iÀ,7] iÀ}iÀƂ]. >ÀÞÌ>˜

(23) ]

(24) ˆiâ]>ÀÌ,] VŽ>À`Ì KU, Kasiske BL, McCullough PA, *>ÃÓ>˜,-]

(25) iœ>V --]*՘*],ˆÌâ ° Cardiovascular disease in chronic kidney disease. A clinical update from Kidney

(26) ˆÃi>Ãi\“«ÀœÛˆ˜}œL>"ÕÌVœ“ià ­

(27) "®°Kidney Int 2011;80:572-586. È° œÀˆ>˜ˆ]->ÛiˆiÛ>]

(28) >˜Ƃ]

(29) i >Àœ  ]iÀÀœ ]ÃÀ>i 7]>˜i

(30) Ƃ]> >˜˜>]œÀ̜˜]ˆÌ>˜ÃƂ]6œÃ Ƃ] /ÕÀ>Ž ˆ> *] ˆ« 9° Àœ˜ˆV kidney disease in patients with cardiac. rhythm disturbances or implantable iiVÌÀˆV>`iۈViÃ\Vˆ˜ˆV>È}˜ˆwV>˜Vi and implications for decision making-a position paper of the European Heart Rhythm Association endorsed by the Heart Rhythm Society and the Asia *>VˆwVi>ÀÌ, ÞÌ “-œVˆiÌÞ°Europace 2015;17:1169-1196. Ç° œ˜`œ˜]*>˜˜ˆiÀ ]>ÀV >ˆÃ-] ÕiÀˆ˜Ƃ*° >VˆwV>̈œ˜œvÌ i>œÀ̈V Û>Ûiˆ˜Ì i`ˆ>Þâi`«>̈i˜Ì°J Am Soc Nephrol 2000;11:778-783. n° ˆ“

(31) ] - ˆ“ 9] œ˜} ,] œ ]. >˜}]>7] ՘} ° vviVÌœv End-Stage Renal Disease on Rate of Progression of Aortic Stenosis. Am J Cardiol 2016;117:1972-1977. 9. Zimmerman D, Sood MM, Rigatto C, Holden RM, Hiremath S, Clase CM. Systematic review and meta-analysis of incidence, prevalence and outcomes of >ÌÀˆ>wLÀˆ>̈œ˜ˆ˜«>̈i˜ÌÃœ˜`ˆ>ÞÈð Nephrol Dial Transplant 2012;27:38163822. £ä°œ`ÃÌiˆ˜ Ƃ]ƂÀVi ]>̎ÞƂ] /ÕÀ>Ž ˆ>]-i̜}ÕV ˆ-]7ˆ˜Ži“>ÞiÀ 7 °/Ài˜`È˜Ì iˆ˜Vˆ`i˜Viœv>ÌÀˆ> wLÀˆ>̈œ˜ˆ˜œ`iÀ«>̈i˜ÌȘˆÌˆ>̈˜} dialysis in the United States. Circulation 2012;126:2293-2301. 11.*ˆVVˆ˜ˆ *] >““ˆ ] -ˆ˜˜iÀ ] i˜Ãi˜* ]iÀ˜>˜`iâƂ]iVŽLiÀÌ -,] i˜>“ˆ˜ ] ÕÀ̈ð˜Vˆ`i˜Vi >˜`«ÀiÛ>i˜Viœv>ÌÀˆ>wLÀˆ>̈œ˜>˜` associated mortality among Medicare Li˜iwVˆ>ÀˆiÃ]£™™Î‡ÓääÇ°Circ Cardiovasc Qual Outcomes 2012;5:85-93. £Ó°ƂiÃÈi ] ƂÕÓ> ] -V œÌÌi˜ 1° Electrical, contractile and structural Ài“œ`iˆ˜}`ÕÀˆ˜}>ÌÀˆ>wLÀˆ>̈œ˜°. 13.

(32) Chapter 1 Cardiovasc Res 2002;54:230-246. £Î°œÀ>˜Ì✫œÕœÃ*]œŽŽœÀˆÃ-]ˆÕ/] *ÀœÌœ«Ã>ÌˆÃ]ˆ]œÕ`iÛi˜œÃƂ° ƂÌÀˆ> wLÀˆ>̈œ˜ ˆ˜ i˜`‡ÃÌ>}i Ài˜> disease. Pacing Clin Electrophysiol 2007;30:1391-1397. £{°>˜},] >`>˜œ*]œÀ‡Ƃۈ6]Ƃw>œ ]ƂÀ“ÃÌÀœ˜}Ƃ] À˜>˜`i]>V Î>“«v Ƃ]œÃÌiÀ ]œ`ÃÌiˆ˜-Ƃ]Õâ˜iÌÜÛ> T, Lancellotti P, Muraru D, Picard MH, ,ˆiÌâÃV i ,],Õ`Έ]-«i˜ViÀ/] /Ã>˜}7]6œˆ}Ì1°,iVœ““i˜`>̈œ˜Ã for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging 2015;16:233-270. £x°*>ޘi]- >À“>-]

(33) iiœ˜

(34) ]Õ] Alemu F, Balogun RA, Malakauskas SM, Kalantar-Zadeh K, Kovesdy CP. Association of echocardiographic abnormalities with mortality in men with non-dialysis-dependent chronic kidney disease. Nephrol Dial Transplant 2012;27:694-700. £È°*>ÀvÀiÞ*-]œiÞ, ]>À˜iÌÌ

(35) ]i˜Ì ]ÕÀÀ>Þ

(36) ] >ÀÀi* °"ÕÌVœ“i and risk factors for left ventricular disorders in chronic uraemia. Nephrol Dial Transplant 1996;11:1277-1285. 17. Unger ED, Dubin RF, Deo R, Daruwalla 6]Àˆi`“>˜]i`ˆ˜> ] iÕÃȘŽ ]Àii` ]- > -°ƂÃÜVˆ>̈œ˜œv chronic kidney disease with abnormal cardiac mechanic s and adverse outcomes in patients with heart failure and preserved ejection fraction. Eur J Heart Fail 2016;18:103-112. £n°/œ«Ã]

(37) i}>`œ6]>ÀÃ>˜ Ƃ] >Ý. 14. °ޜV>À`ˆ>ÃÌÀ>ˆ˜̜`iÌiVÌÃÕL̏i left ventricular systolic dysfunction. Eur J Heart Fail 2017;19:307-313. £™°>>“ ] "Ì> > *] >À ܈VŽ /° *Àœ}˜œÃ̈Vˆ“«ˆV>̈œ˜Ãœv}œL>6 dysfunction: a systematic review and meta-analysis of global longitudinal strain and ejection fraction. Heart 2014;100:1673-1680. Óä°ÀiÞLi ] ââi``ˆ˜i ,] i`ˆ ] >ÀÀˆ˜}̜˜7] >â>â,]>˜â]>ˆ˜ -] }ÜÕ"]œ˜`œ˜ ]->L>-°,i˜> ˆ˜ÃÕvwVˆi˜VÞ«Ài`ˆVÌÃÌ ï“i̜wÀÃÌ >««Àœ«Àˆ>Ìi `iwLÀˆ>̜À à œVŽ° Am Heart J 2006;151:852-856. 21. Makki N, Swaminathan PD, Hanmer ] "Ã >˜ÃŽÞ °

(38) œ ˆ“«>˜Ì>Li cardioverter defibrillators improve survival in patients with chronic kidney disease at high risk of sudden cardiac death? A meta-analysis of observational studies. Europace 2014;16:55-62. ÓÓ° ՈÌi˜ -]

(39) i ˆi ] 6>˜

(40) iÀ iˆ`i˜Ƃ ],œÌ“>˜Ã] œœÌÓ>] >ÀVÀœi˜iÛi`]7œÌiÀLiiŽ,] ,>Liˆ˜Ž/]Վi“>7]-V >ˆ]6>˜ Erven L. Chronic kidney disease and ˆ“«>˜Ì>LiV>À`ˆœÛiÀÌiÀ`iwLÀˆ>̜À related complications: 16 years of iÝ«iÀˆi˜Vi°J Cardiovasc Electrophysiol 2014;25:998-1004. Óΰ՘} ] >Àœ˜] ÕÌV >ÀÌ ]

(41) i> >Þi ] œ Ži‡ >Àܜv ] iÛ>˜} "7] /œÀ˜œÃ*]6>˜œÛiÀÃV i`i]6iÀ“iiÀ ] œiÀÓ> ],>Û>Õ`*]6> >˜ˆ>˜Ƃ° A prospective survey of patients with valvular heart disease in Europe: The ÕÀœi>ÀÌ-ÕÀÛiÞœ˜6>ÛՏ>Ài>ÀÌ Disease. Eur Heart J 2003;24:1231-1243. Ó{°iÀâœ} Ƃ]><] œˆ˜ÃƂ°œ˜}‡ÌiÀ“ survival of dialysis patients in the United.

(42) General Introduction States with prosthetic heart valves: à œÕ`Ƃ. ÉƂƂ«À>V̈Vi}Ո`iˆ˜iÃœ˜ Û>ÛiÃiiV̈œ˜Li“œ`ˆwi`¶Circulation 2002;105:1336-1341. Óx° ˆÃ ˆ“ÕÀ>,Ƃ]"Ì̜ ] œ˜œÜ,"]. >À>Liœ Ƃ] À܈˜*]ÎÀ`]ÕÞ̜˜,Ƃ] "½>À>*/],Ոâ ]-ŽÕL>à ]-œÀ>>*] -՘`Ì/]ÎÀ`]/ œ“>Ã

(43) °Óä£{ƂƂÉ ACC guideline for the management of patients with valvular heart disease: a report of the American College of. >À`ˆœœ}ÞÉƂ“iÀˆV>˜i>ÀÌƂÃÜVˆ>̈œ˜ />ÎœÀViœ˜*À>V̈ViՈ`iˆ˜iðJ Am Coll Cardiol 2014;63:e57-185. ÓÈ°,>}}ˆ*] i>ÈƂ]>“Lœ> ]iÀÀ>“œÃV> ],>Ì̈ ] œVŽƂ]՘̘iÀ*°Ƃ‡ cause mortality in hemodialysis patients ÜˆÌ  i>ÀÌÛ>ÛiV>VˆwV>̈œ˜°Clin J Am Soc Nephrol 2011;6:1990-1995. 27. Takahashi H, Ishii H, Aoyama T, Kamoi D, Kasuga H, Ito Y, Yasuda K, Tanaka M, Yoshikawa D, Maruyama S, Matsuo -]ÕÀœ >À>/]9Õâ>Ü>9°ƂÃÜVˆ>̈œ˜ œvV>À`ˆ>VÛ>ÛՏ>ÀV>VˆwV>̈œ˜Ã>˜` C-reactive protein with cardiovascular mortality in incident hemodialysis «>̈i˜ÌÃ\>>«>˜iÃiVœ œÀÌÃÌÕ`Þ°Am J Kidney Dis 2013;61:254-261.. 15.

(44)

(45)

Referenties

GERELATEERDE DOCUMENTEN

The prevalence of ventricular conduction disorders increased in parallel with AS severity, which was particularly significant for left bundle branch block (4.3% in aortic

(1999) 40 Prospective Mean time since event 12 and 36 mo 145 To 191 pts, 142 caregivers HT patients that survived 6 weeks after surgery SCID interview (DSM-III-R ) on

Chapter 6 Prevalence and prognostic implications of mitral and aortic valve calcium in patients with chronic kidney

On all subscales of the MFI, patients reported more fatigue compared with norms of the general population, both before and 1 year after surgery.. In total, 68% and 57% of

Daar word egter self erken dat alhoewel daar die behoefte is om die gemeente se fokus alhoemeer te verskuif van onmiddelike verligting tot langtermyn ontwikkeling, dit nog ‘n

Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners and it is a condition of

Om de voer- opname te verbeteren wordt nu bij alle stations extra water tijdens het voeren vertrekt, Buiten het voerstation kan altijd onbeperkt water wor- den

The presence of mitral and/or aortic valve calcium was associated with poor survival in this population, but only mitral valve cal- cium was independently associated with increased